nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP2C8—Mometasone—systemic scleroderma	0.0959	0.132	CbGbCtD
Phenobarbital—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0792	0.109	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—systemic scleroderma	0.0699	0.0964	CbGbCtD
Phenobarbital—CYP1A2—Pentoxifylline—systemic scleroderma	0.0501	0.0691	CbGbCtD
Phenobarbital—CYP1A2—Leflunomide—systemic scleroderma	0.0478	0.0659	CbGbCtD
Phenobarbital—ABCB1—Lisinopril—systemic scleroderma	0.0438	0.0604	CbGbCtD
Phenobarbital—CYP2C9—Leflunomide—systemic scleroderma	0.0431	0.0594	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—systemic scleroderma	0.0429	0.0592	CbGbCtD
Phenobarbital—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0397	0.0547	CbGbCtD
Phenobarbital—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0382	0.0526	CbGbCtD
Phenobarbital—ABCB1—Captopril—systemic scleroderma	0.0328	0.0452	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—systemic scleroderma	0.0318	0.0438	CbGbCtD
Phenobarbital—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0258	0.0356	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—systemic scleroderma	0.0256	0.0353	CbGbCtD
Phenobarbital—ABCB1—Prednisone—systemic scleroderma	0.0207	0.0285	CbGbCtD
Phenobarbital—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0155	0.0213	CbGbCtD
Phenobarbital—CYP3A4—Prednisone—systemic scleroderma	0.0124	0.0171	CbGbCtD
Phenobarbital—CYP2C9—cardial valve—systemic scleroderma	0.0108	0.233	CbGeAlD
Phenobarbital—ABCB1—Methotrexate—systemic scleroderma	0.0104	0.0143	CbGbCtD
Phenobarbital—CYP4A11—digestive system—systemic scleroderma	0.00215	0.0462	CbGeAlD
Phenobarbital—CYP4B1—digestive system—systemic scleroderma	0.00192	0.0412	CbGeAlD
Phenobarbital—CYP4B1—tendon—systemic scleroderma	0.00183	0.0393	CbGeAlD
Phenobarbital—CYP4B1—lung—systemic scleroderma	0.0016	0.0344	CbGeAlD
Phenobarbital—SLCO2A1—skin of body—systemic scleroderma	0.00143	0.0308	CbGeAlD
Phenobarbital—CYP2C18—digestive system—systemic scleroderma	0.00142	0.0306	CbGeAlD
Phenobarbital—ABCB11—digestive system—systemic scleroderma	0.00138	0.0298	CbGeAlD
Phenobarbital—CHRNA7—skin of body—systemic scleroderma	0.00118	0.0253	CbGeAlD
Phenobarbital—SLCO2A1—tendon—systemic scleroderma	0.00109	0.0235	CbGeAlD
Phenobarbital—SLCO2A1—lung—systemic scleroderma	0.000958	0.0206	CbGeAlD
Phenobarbital—CYP1B1—connective tissue—systemic scleroderma	0.000955	0.0205	CbGeAlD
Phenobarbital—CHRNA7—digestive system—systemic scleroderma	0.000941	0.0202	CbGeAlD
Phenobarbital—CHRNA4—digestive system—systemic scleroderma	0.000929	0.02	CbGeAlD
Phenobarbital—Erythema multiforme—Captopril—systemic scleroderma	0.000884	0.00388	CcSEcCtD
Phenobarbital—Confusional state—Pentoxifylline—systemic scleroderma	0.000884	0.00388	CcSEcCtD
Phenobarbital—ABCC3—digestive system—systemic scleroderma	0.000881	0.0189	CbGeAlD
Phenobarbital—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.000878	0.00385	CcSEcCtD
Phenobarbital—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000873	0.0188	CbGeAlD
Phenobarbital—Shock—Pentoxifylline—systemic scleroderma	0.000863	0.00378	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000862	0.00378	CcSEcCtD
Phenobarbital—CYP1B1—skin of body—systemic scleroderma	0.000862	0.0185	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.000851	0.00373	CcSEcCtD
Phenobarbital—Angioedema—Mometasone—systemic scleroderma	0.000847	0.00372	CcSEcCtD
Phenobarbital—Renal failure—Leflunomide—systemic scleroderma	0.000844	0.0037	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—systemic scleroderma	0.000834	0.00366	CcSEcCtD
Phenobarbital—Asthma—Lisinopril—systemic scleroderma	0.000828	0.00363	CcSEcCtD
Phenobarbital—Affect lability—Mycophenolate mofetil—systemic scleroderma	0.000826	0.00362	CcSEcCtD
Phenobarbital—Hypotension—Pentoxifylline—systemic scleroderma	0.000819	0.00359	CcSEcCtD
Phenobarbital—Renal failure—Mycophenolic acid—systemic scleroderma	0.000805	0.00353	CcSEcCtD
Phenobarbital—Tension—Captopril—systemic scleroderma	0.000799	0.0035	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000799	0.0035	CcSEcCtD
Phenobarbital—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00349	CcSEcCtD
Phenobarbital—Nervousness—Captopril—systemic scleroderma	0.000791	0.00347	CcSEcCtD
Phenobarbital—Myalgia—Mometasone—systemic scleroderma	0.000789	0.00346	CcSEcCtD
Phenobarbital—Arthralgia—Mometasone—systemic scleroderma	0.000789	0.00346	CcSEcCtD
Phenobarbital—CYP2A6—lung—systemic scleroderma	0.000786	0.0169	CbGeAlD
Phenobarbital—Somnolence—Pentoxifylline—systemic scleroderma	0.00078	0.00342	CcSEcCtD
Phenobarbital—CHRNA4—lung—systemic scleroderma	0.000776	0.0167	CbGeAlD
Phenobarbital—Apnoea—Methotrexate—systemic scleroderma	0.000772	0.00339	CcSEcCtD
Phenobarbital—Erythema multiforme—Azathioprine—systemic scleroderma	0.000772	0.00339	CcSEcCtD
Phenobarbital—Hepatitis—Leflunomide—systemic scleroderma	0.000771	0.00338	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—systemic scleroderma	0.00075	0.00329	CcSEcCtD
Phenobarbital—Constipation—Pentoxifylline—systemic scleroderma	0.00075	0.00329	CcSEcCtD
Phenobarbital—Bradycardia—Mycophenolic acid—systemic scleroderma	0.000749	0.00328	CcSEcCtD
Phenobarbital—Angioedema—Captopril—systemic scleroderma	0.000744	0.00326	CcSEcCtD
Phenobarbital—ABCC3—lung—systemic scleroderma	0.000736	0.0158	CbGeAlD
Phenobarbital—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000735	0.00323	CcSEcCtD
Phenobarbital—Hallucination—Mycophenolic acid—systemic scleroderma	0.000732	0.00321	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000732	0.00321	CcSEcCtD
Phenobarbital—Syncope—Captopril—systemic scleroderma	0.00073	0.0032	CcSEcCtD
Phenobarbital—Erythema multiforme—Leflunomide—systemic scleroderma	0.000729	0.0032	CcSEcCtD
Phenobarbital—Renal failure—Lisinopril—systemic scleroderma	0.000725	0.00318	CcSEcCtD
Phenobarbital—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00318	CcSEcCtD
Phenobarbital—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000723	0.00317	CcSEcCtD
Phenobarbital—Loss of consciousness—Captopril—systemic scleroderma	0.000716	0.00314	CcSEcCtD
Phenobarbital—ABCC2—digestive system—systemic scleroderma	0.000704	0.0151	CbGeAlD
Phenobarbital—Urticaria—Pentoxifylline—systemic scleroderma	0.000697	0.00306	CcSEcCtD
Phenobarbital—Myalgia—Captopril—systemic scleroderma	0.000693	0.00304	CcSEcCtD
Phenobarbital—Arthralgia—Captopril—systemic scleroderma	0.000693	0.00304	CcSEcCtD
Phenobarbital—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000693	0.00304	CcSEcCtD
Phenobarbital—CYP1B1—digestive system—systemic scleroderma	0.000689	0.0148	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000689	0.00302	CcSEcCtD
Phenobarbital—ABCB1—blood vessel—systemic scleroderma	0.000684	0.0147	CbGeAlD
Phenobarbital—Hyperkinesia—Prednisone—systemic scleroderma	0.000683	0.003	CcSEcCtD
Phenobarbital—Bradycardia—Lisinopril—systemic scleroderma	0.000674	0.00296	CcSEcCtD
Phenobarbital—Confusional state—Captopril—systemic scleroderma	0.00067	0.00294	CcSEcCtD
Phenobarbital—ABCC2—tendon—systemic scleroderma	0.00067	0.0144	CbGeAlD
Phenobarbital—Respiratory failure—Methotrexate—systemic scleroderma	0.000667	0.00292	CcSEcCtD
Phenobarbital—Hepatitis—Lisinopril—systemic scleroderma	0.000662	0.00291	CcSEcCtD
Phenobarbital—Hallucination—Lisinopril—systemic scleroderma	0.000659	0.00289	CcSEcCtD
Phenobarbital—CYP1B1—tendon—systemic scleroderma	0.000656	0.0141	CbGeAlD
Phenobarbital—Shock—Captopril—systemic scleroderma	0.000654	0.00287	CcSEcCtD
Phenobarbital—Pain—Mometasone—systemic scleroderma	0.000647	0.00284	CcSEcCtD
Phenobarbital—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000646	0.00283	CcSEcCtD
Phenobarbital—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00279	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.000632	0.00277	CcSEcCtD
Phenobarbital—Tension—Mycophenolic acid—systemic scleroderma	0.000628	0.00276	CcSEcCtD
Phenobarbital—Erythema multiforme—Lisinopril—systemic scleroderma	0.000626	0.00275	CcSEcCtD
Phenobarbital—Nervousness—Mycophenolic acid—systemic scleroderma	0.000622	0.00273	CcSEcCtD
Phenobarbital—Hypotension—Captopril—systemic scleroderma	0.000621	0.00272	CcSEcCtD
Phenobarbital—Angioedema—Leflunomide—systemic scleroderma	0.000613	0.00269	CcSEcCtD
Phenobarbital—CYP1A1—skin of body—systemic scleroderma	0.000609	0.0131	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000605	0.00266	CcSEcCtD
Phenobarbital—Arthralgia—Azathioprine—systemic scleroderma	0.000605	0.00265	CcSEcCtD
Phenobarbital—Myalgia—Azathioprine—systemic scleroderma	0.000605	0.00265	CcSEcCtD
Phenobarbital—CYP2C19—digestive system—systemic scleroderma	0.000605	0.013	CbGeAlD
Phenobarbital—Vertigo—Leflunomide—systemic scleroderma	0.000603	0.00264	CcSEcCtD
Phenobarbital—Coma—Methotrexate—systemic scleroderma	0.000598	0.00262	CcSEcCtD
Phenobarbital—Body temperature increased—Mometasone—systemic scleroderma	0.000598	0.00262	CcSEcCtD
Phenobarbital—CYP2B6—skin of body—systemic scleroderma	0.000592	0.0127	CbGeAlD
Phenobarbital—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000591	0.00259	CcSEcCtD
Phenobarbital—Somnolence—Captopril—systemic scleroderma	0.000591	0.00259	CcSEcCtD
Phenobarbital—ABCC1—tendon—systemic scleroderma	0.00059	0.0127	CbGeAlD
Phenobarbital—Agitation—Mycophenolic acid—systemic scleroderma	0.000588	0.00258	CcSEcCtD
Phenobarbital—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00058	0.00255	CcSEcCtD
Phenobarbital—Lethargy—Prednisone—systemic scleroderma	0.00058	0.00255	CcSEcCtD
Phenobarbital—Dizziness—Pentoxifylline—systemic scleroderma	0.00058	0.00254	CcSEcCtD
Phenobarbital—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000578	0.00253	CcSEcCtD
Phenobarbital—Erythema—Lisinopril—systemic scleroderma	0.000577	0.00253	CcSEcCtD
Phenobarbital—CYP1B1—lung—systemic scleroderma	0.000576	0.0124	CbGeAlD
Phenobarbital—Vertigo—Mycophenolic acid—systemic scleroderma	0.000575	0.00252	CcSEcCtD
Phenobarbital—Syncope—Mycophenolic acid—systemic scleroderma	0.000574	0.00252	CcSEcCtD
Phenobarbital—Myalgia—Leflunomide—systemic scleroderma	0.000571	0.00251	CcSEcCtD
Phenobarbital—Arthralgia—Leflunomide—systemic scleroderma	0.000571	0.00251	CcSEcCtD
Phenobarbital—Anxiety—Leflunomide—systemic scleroderma	0.000569	0.0025	CcSEcCtD
Phenobarbital—Constipation—Captopril—systemic scleroderma	0.000568	0.00249	CcSEcCtD
Phenobarbital—Tension—Lisinopril—systemic scleroderma	0.000566	0.00248	CcSEcCtD
Phenobarbital—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000563	0.00247	CcSEcCtD
Phenobarbital—Nervousness—Lisinopril—systemic scleroderma	0.00056	0.00246	CcSEcCtD
Phenobarbital—Affect lability—Prednisone—systemic scleroderma	0.00056	0.00245	CcSEcCtD
Phenobarbital—Vomiting—Pentoxifylline—systemic scleroderma	0.000558	0.00245	CcSEcCtD
Phenobarbital—Rash—Pentoxifylline—systemic scleroderma	0.000553	0.00242	CcSEcCtD
Phenobarbital—Dermatitis—Pentoxifylline—systemic scleroderma	0.000552	0.00242	CcSEcCtD
Phenobarbital—Headache—Pentoxifylline—systemic scleroderma	0.000549	0.00241	CcSEcCtD
Phenobarbital—Feeling abnormal—Captopril—systemic scleroderma	0.000548	0.0024	CcSEcCtD
Phenobarbital—Myalgia—Mycophenolic acid—systemic scleroderma	0.000545	0.00239	CcSEcCtD
Phenobarbital—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000545	0.00239	CcSEcCtD
Phenobarbital—Anxiety—Mycophenolic acid—systemic scleroderma	0.000543	0.00238	CcSEcCtD
Phenobarbital—Irritability—Prednisone—systemic scleroderma	0.000543	0.00238	CcSEcCtD
Phenobarbital—Hypotension—Azathioprine—systemic scleroderma	0.000542	0.00238	CcSEcCtD
Phenobarbital—Mood swings—Prednisone—systemic scleroderma	0.000539	0.00236	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000528	0.00232	CcSEcCtD
Phenobarbital—Angioedema—Lisinopril—systemic scleroderma	0.000527	0.00231	CcSEcCtD
Phenobarbital—Confusional state—Mycophenolic acid—systemic scleroderma	0.000527	0.00231	CcSEcCtD
Phenobarbital—Body temperature increased—Captopril—systemic scleroderma	0.000525	0.0023	CcSEcCtD
Phenobarbital—Nausea—Pentoxifylline—systemic scleroderma	0.000521	0.00228	CcSEcCtD
Phenobarbital—Vertigo—Lisinopril—systemic scleroderma	0.000518	0.00227	CcSEcCtD
Phenobarbital—ABCC1—lung—systemic scleroderma	0.000518	0.0111	CbGeAlD
Phenobarbital—Syncope—Lisinopril—systemic scleroderma	0.000517	0.00227	CcSEcCtD
Phenobarbital—Shock—Mycophenolic acid—systemic scleroderma	0.000514	0.00225	CcSEcCtD
Phenobarbital—Hypotension—Leflunomide—systemic scleroderma	0.000512	0.00224	CcSEcCtD
Phenobarbital—Loss of consciousness—Lisinopril—systemic scleroderma	0.000507	0.00222	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000504	0.00221	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000499	0.00219	CcSEcCtD
Phenobarbital—Tension—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00217	CcSEcCtD
Phenobarbital—CYP1A2—digestive system—systemic scleroderma	0.000494	0.0106	CbGeAlD
Phenobarbital—Arthralgia—Lisinopril—systemic scleroderma	0.000491	0.00215	CcSEcCtD
Phenobarbital—Myalgia—Lisinopril—systemic scleroderma	0.000491	0.00215	CcSEcCtD
Phenobarbital—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00215	CcSEcCtD
Phenobarbital—Anxiety—Lisinopril—systemic scleroderma	0.000489	0.00215	CcSEcCtD
Phenobarbital—Hypotension—Mycophenolic acid—systemic scleroderma	0.000488	0.00214	CcSEcCtD
Phenobarbital—CYP1A1—digestive system—systemic scleroderma	0.000487	0.0105	CbGeAlD
Phenobarbital—Lethargy—Methotrexate—systemic scleroderma	0.000485	0.00213	CcSEcCtD
Phenobarbital—Vomiting—Mometasone—systemic scleroderma	0.000481	0.00211	CcSEcCtD
Phenobarbital—Feeling abnormal—Azathioprine—systemic scleroderma	0.000478	0.0021	CcSEcCtD
Phenobarbital—Rash—Mometasone—systemic scleroderma	0.000477	0.00209	CcSEcCtD
Phenobarbital—Dermatitis—Mometasone—systemic scleroderma	0.000477	0.00209	CcSEcCtD
Phenobarbital—CYP3A5—digestive system—systemic scleroderma	0.000477	0.0102	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000476	0.00209	CcSEcCtD
Phenobarbital—Confusional state—Lisinopril—systemic scleroderma	0.000475	0.00208	CcSEcCtD
Phenobarbital—Headache—Mometasone—systemic scleroderma	0.000474	0.00208	CcSEcCtD
Phenobarbital—CYP2B6—digestive system—systemic scleroderma	0.000474	0.0102	CbGeAlD
Phenobarbital—CYP2C9—digestive system—systemic scleroderma	0.000469	0.0101	CbGeAlD
Phenobarbital—Constipation—Leflunomide—systemic scleroderma	0.000468	0.00205	CcSEcCtD
Phenobarbital—Pain—Leflunomide—systemic scleroderma	0.000468	0.00205	CcSEcCtD
Phenobarbital—Somnolence—Mycophenolic acid—systemic scleroderma	0.000465	0.00204	CcSEcCtD
Phenobarbital—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000464	0.00204	CcSEcCtD
Phenobarbital—Shock—Lisinopril—systemic scleroderma	0.000463	0.00203	CcSEcCtD
Phenobarbital—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000462	0.00202	CcSEcCtD
Phenobarbital—Body temperature increased—Azathioprine—systemic scleroderma	0.000459	0.00201	CcSEcCtD
Phenobarbital—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000454	0.00199	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—systemic scleroderma	0.000454	0.00199	CcSEcCtD
Phenobarbital—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000453	0.00199	CcSEcCtD
Phenobarbital—Feeling abnormal—Leflunomide—systemic scleroderma	0.000451	0.00198	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—systemic scleroderma	0.00045	0.00197	CcSEcCtD
Phenobarbital—Nausea—Mometasone—systemic scleroderma	0.000449	0.00197	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—systemic scleroderma	0.000447	0.00196	CcSEcCtD
Phenobarbital—Pain—Mycophenolic acid—systemic scleroderma	0.000447	0.00196	CcSEcCtD
Phenobarbital—Constipation—Mycophenolic acid—systemic scleroderma	0.000447	0.00196	CcSEcCtD
Phenobarbital—CYP2E1—digestive system—systemic scleroderma	0.000444	0.00956	CbGeAlD
Phenobarbital—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00195	CcSEcCtD
Phenobarbital—Hypotension—Lisinopril—systemic scleroderma	0.00044	0.00193	CcSEcCtD
Phenobarbital—Dizziness—Captopril—systemic scleroderma	0.000439	0.00193	CcSEcCtD
Phenobarbital—Urticaria—Leflunomide—systemic scleroderma	0.000435	0.00191	CcSEcCtD
Phenobarbital—Body temperature increased—Leflunomide—systemic scleroderma	0.000433	0.0019	CcSEcCtD
Phenobarbital—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000431	0.00189	CcSEcCtD
Phenobarbital—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00189	CcSEcCtD
Phenobarbital—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00043	0.00189	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000429	0.00188	CcSEcCtD
Phenobarbital—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00188	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000428	0.00188	CcSEcCtD
Phenobarbital—Hypersensitivity—Azathioprine—systemic scleroderma	0.000427	0.00187	CcSEcCtD
Phenobarbital—CYP2E1—tendon—systemic scleroderma	0.000423	0.0091	CbGeAlD
Phenobarbital—Vomiting—Captopril—systemic scleroderma	0.000423	0.00185	CcSEcCtD
Phenobarbital—Rash—Captopril—systemic scleroderma	0.000419	0.00184	CcSEcCtD
Phenobarbital—Dermatitis—Captopril—systemic scleroderma	0.000419	0.00184	CcSEcCtD
Phenobarbital—Somnolence—Lisinopril—systemic scleroderma	0.000418	0.00183	CcSEcCtD
Phenobarbital—Headache—Captopril—systemic scleroderma	0.000416	0.00183	CcSEcCtD
Phenobarbital—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00182	CcSEcCtD
Phenobarbital—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000413	0.00181	CcSEcCtD
Phenobarbital—CYP1A2—lung—systemic scleroderma	0.000413	0.00887	CbGeAlD
Phenobarbital—Asthma—Methotrexate—systemic scleroderma	0.000411	0.0018	CcSEcCtD
Phenobarbital—CYP1A1—lung—systemic scleroderma	0.000407	0.00875	CbGeAlD
Phenobarbital—Shock—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00178	CcSEcCtD
Phenobarbital—Hypersensitivity—Leflunomide—systemic scleroderma	0.000404	0.00177	CcSEcCtD
Phenobarbital—Pain—Lisinopril—systemic scleroderma	0.000402	0.00177	CcSEcCtD
Phenobarbital—Constipation—Lisinopril—systemic scleroderma	0.000402	0.00177	CcSEcCtD
Phenobarbital—Bradycardia—Prednisone—systemic scleroderma	0.000401	0.00176	CcSEcCtD
Phenobarbital—CYP3A5—lung—systemic scleroderma	0.000398	0.00856	CbGeAlD
Phenobarbital—CYP2B6—lung—systemic scleroderma	0.000396	0.00851	CbGeAlD
Phenobarbital—Nausea—Captopril—systemic scleroderma	0.000395	0.00173	CcSEcCtD
Phenobarbital—Hallucination—Prednisone—systemic scleroderma	0.000391	0.00172	CcSEcCtD
Phenobarbital—Feeling abnormal—Lisinopril—systemic scleroderma	0.000388	0.0017	CcSEcCtD
Phenobarbital—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000385	0.00169	CcSEcCtD
Phenobarbital—Dizziness—Azathioprine—systemic scleroderma	0.000384	0.00168	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00165	CcSEcCtD
Phenobarbital—Urticaria—Lisinopril—systemic scleroderma	0.000374	0.00164	CcSEcCtD
Phenobarbital—Body temperature increased—Lisinopril—systemic scleroderma	0.000372	0.00163	CcSEcCtD
Phenobarbital—CYP2E1—lung—systemic scleroderma	0.000371	0.00798	CbGeAlD
Phenobarbital—Vomiting—Azathioprine—systemic scleroderma	0.000369	0.00162	CcSEcCtD
Phenobarbital—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00161	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—systemic scleroderma	0.000366	0.00161	CcSEcCtD
Phenobarbital—Rash—Azathioprine—systemic scleroderma	0.000366	0.0016	CcSEcCtD
Phenobarbital—Dermatitis—Azathioprine—systemic scleroderma	0.000365	0.0016	CcSEcCtD
Phenobarbital—Headache—Azathioprine—systemic scleroderma	0.000363	0.00159	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000363	0.00159	CcSEcCtD
Phenobarbital—Dizziness—Leflunomide—systemic scleroderma	0.000362	0.00159	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—systemic scleroderma	0.00036	0.00158	CcSEcCtD
Phenobarbital—CYP3A4—digestive system—systemic scleroderma	0.000358	0.00769	CbGeAlD
Phenobarbital—Pain—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00155	CcSEcCtD
Phenobarbital—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00155	CcSEcCtD
Phenobarbital—Vomiting—Leflunomide—systemic scleroderma	0.000348	0.00153	CcSEcCtD
Phenobarbital—Hypersensitivity—Lisinopril—systemic scleroderma	0.000347	0.00152	CcSEcCtD
Phenobarbital—Dizziness—Mycophenolic acid—systemic scleroderma	0.000346	0.00152	CcSEcCtD
Phenobarbital—Rash—Leflunomide—systemic scleroderma	0.000345	0.00151	CcSEcCtD
Phenobarbital—Dermatitis—Leflunomide—systemic scleroderma	0.000345	0.00151	CcSEcCtD
Phenobarbital—Nausea—Azathioprine—systemic scleroderma	0.000345	0.00151	CcSEcCtD
Phenobarbital—Headache—Leflunomide—systemic scleroderma	0.000343	0.0015	CcSEcCtD
Phenobarbital—Erythema—Prednisone—systemic scleroderma	0.000342	0.0015	CcSEcCtD
Phenobarbital—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00149	CcSEcCtD
Phenobarbital—Vomiting—Mycophenolic acid—systemic scleroderma	0.000332	0.00146	CcSEcCtD
Phenobarbital—Rash—Mycophenolic acid—systemic scleroderma	0.000329	0.00144	CcSEcCtD
Phenobarbital—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000329	0.00144	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—systemic scleroderma	0.000329	0.00144	CcSEcCtD
Phenobarbital—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000328	0.00144	CcSEcCtD
Phenobarbital—Headache—Mycophenolic acid—systemic scleroderma	0.000327	0.00144	CcSEcCtD
Phenobarbital—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000326	0.00143	CcSEcCtD
Phenobarbital—Nausea—Leflunomide—systemic scleroderma	0.000325	0.00143	CcSEcCtD
Phenobarbital—Agitation—Prednisone—systemic scleroderma	0.000315	0.00138	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—systemic scleroderma	0.000313	0.00137	CcSEcCtD
Phenobarbital—Dizziness—Lisinopril—systemic scleroderma	0.000311	0.00136	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—systemic scleroderma	0.000311	0.00136	CcSEcCtD
Phenobarbital—Nausea—Mycophenolic acid—systemic scleroderma	0.00031	0.00136	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—systemic scleroderma	0.000308	0.00135	CcSEcCtD
Phenobarbital—Syncope—Prednisone—systemic scleroderma	0.000307	0.00135	CcSEcCtD
Phenobarbital—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00133	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisone—systemic scleroderma	0.000301	0.00132	CcSEcCtD
Phenobarbital—Vomiting—Lisinopril—systemic scleroderma	0.000299	0.00131	CcSEcCtD
Phenobarbital—Rash—Lisinopril—systemic scleroderma	0.000297	0.0013	CcSEcCtD
Phenobarbital—Dermatitis—Lisinopril—systemic scleroderma	0.000296	0.0013	CcSEcCtD
Phenobarbital—Headache—Lisinopril—systemic scleroderma	0.000295	0.00129	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—systemic scleroderma	0.000292	0.00128	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—systemic scleroderma	0.000292	0.00128	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—systemic scleroderma	0.000291	0.00127	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—systemic scleroderma	0.000286	0.00126	CcSEcCtD
Phenobarbital—Nausea—Lisinopril—systemic scleroderma	0.00028	0.00123	CcSEcCtD
Phenobarbital—Shock—Prednisone—systemic scleroderma	0.000275	0.00121	CcSEcCtD
Phenobarbital—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000273	0.0012	CcSEcCtD
Phenobarbital—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00115	CcSEcCtD
Phenobarbital—Rash—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00114	CcSEcCtD
Phenobarbital—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00114	CcSEcCtD
Phenobarbital—Headache—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00113	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—systemic scleroderma	0.000257	0.00113	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000255	0.00112	CcSEcCtD
Phenobarbital—ABCB1—digestive system—systemic scleroderma	0.000253	0.00544	CbGeAlD
Phenobarbital—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00107	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—systemic scleroderma	0.000244	0.00107	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—systemic scleroderma	0.000244	0.00107	CcSEcCtD
Phenobarbital—Constipation—Prednisone—systemic scleroderma	0.000239	0.00105	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—systemic scleroderma	0.000236	0.00103	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—systemic scleroderma	0.00023	0.00101	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—systemic scleroderma	0.000222	0.000974	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—systemic scleroderma	0.000221	0.000969	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—systemic scleroderma	0.000218	0.000957	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000213	0.000933	CcSEcCtD
Phenobarbital—ABCB1—lung—systemic scleroderma	0.000211	0.00455	CbGeAlD
Phenobarbital—Somnolence—Methotrexate—systemic scleroderma	0.000208	0.000911	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisone—systemic scleroderma	0.000206	0.000903	CcSEcCtD
Phenobarbital—Pain—Methotrexate—systemic scleroderma	0.0002	0.000876	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—systemic scleroderma	0.000193	0.000844	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—systemic scleroderma	0.000186	0.000814	CcSEcCtD
Phenobarbital—Dizziness—Prednisone—systemic scleroderma	0.000185	0.000811	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—systemic scleroderma	0.000185	0.00081	CcSEcCtD
Phenobarbital—Vomiting—Prednisone—systemic scleroderma	0.000178	0.000779	CcSEcCtD
Phenobarbital—Rash—Prednisone—systemic scleroderma	0.000176	0.000773	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—systemic scleroderma	0.000176	0.000772	CcSEcCtD
Phenobarbital—Headache—Prednisone—systemic scleroderma	0.000175	0.000768	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—systemic scleroderma	0.000172	0.000755	CcSEcCtD
Phenobarbital—Nausea—Prednisone—systemic scleroderma	0.000166	0.000728	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—systemic scleroderma	0.000154	0.000677	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—systemic scleroderma	0.000149	0.000651	CcSEcCtD
Phenobarbital—Rash—Methotrexate—systemic scleroderma	0.000147	0.000646	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—systemic scleroderma	0.000147	0.000645	CcSEcCtD
Phenobarbital—Headache—Methotrexate—systemic scleroderma	0.000146	0.000642	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—systemic scleroderma	0.000139	0.000609	CcSEcCtD
